
Reasoned opinion on the modification of the existing MRLs for fenhexamid in currants and beans with pods
Publication year - 2013
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2013.3110
Subject(s) - member states , european commission , toxicology , agricultural science , member state , consumer safety , microbiology and biotechnology , environmental health , medicine , business , european union , risk analysis (engineering) , biology , economic policy
In accordance with Article 6 of Regulation (EC) No 396/2005, the United Kingdom, hereafter referred to as the evaluating Member State (EMS‐UK), received an application from Bayer CropScience Ltd. to modify the existing MRL for the active substance fenhexamid in currants. In order to accommodate for the intended use of fenhexamid, the United Kingdom proposed to raise the existing MRL from 5 mg/kg to 15 mg/kg. In accordance with Article 6 of Regulation (EC) No 396/2005, Germany, hereafter referred to as the evaluating Member State (EMS‐DE), received an application from the Landwirtschaftskammer NRW to modify the existing MRL for the active substance fenhexamid in beans with pods. In order to accommodate for the intended use of fenhexamid, Germany proposed to raise the existing MRL from 2 mg/kg to 5 mg/kg. Each of the EMS, the United Kingdom and Germany, drafted an evaluation report in accordance with Article 8 of Regulation (EC) No 396/2005, which was submitted to the European Commission and forwarded to EFSA. According to EFSA the data are sufficient to derive MRL proposals of 15 mg/kg for the proposed use on currants and of 5 mg/kg for the proposed use on beans with pods. Adequate analytical enforcement methods are available to control the residues of fenhexamid in the crops under consideration. Based on the risk assessment results, EFSA concludes that the proposed uses of fenhexamid on currants and beans with pods will not result in a consumer exposure exceeding the toxicological reference value and therefore are unlikely to pose a consumer health risk.